All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @performancemedicinetn on TikTok · 33s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @performancemedicinetn's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00The reason the testosterone pellets are the answer is that not only does it take the symptoms
  2. 0:05away of the menopause like all the stuff we just talked about, it's very protective,
  3. 0:12but it also helps prevent the recurrence of breast cancer and breast cancer patients.
  4. 0:17And it also prevents you from coming now with breast cancer, at least it gives you a lot
  5. 0:23lower chance of it if you have no breast cancer and take testosterone pellets.

Testosterone pellets for breast cancer prevention? We checked

Performance Med

TikTok creator

5.5K viewsWatch on TikTok

Quick answer

The creator claims subcutaneous testosterone pellets both prevent breast cancer in healthy women and reduce recurrence in breast cancer survivors, citing no evidence. Observational data from Glaser et al. (2013, 2019, Maturitas) shows association, not causation, and no major oncology guideline endorses testosterone for breast cancer prevention or recurrence reduction. Women considering testosterone therapy for menopause or survivorship symptoms should consult an oncologist or endocrinologist, not make decisions based on unqualified prevention claims.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Testosterone pellets for breast cancer prevention? We checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Testosterone pellets for breast cancer prevention? We checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Testosterone pellets for breast cancer prevention? We checked" from Performance Med. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator claims subcutaneous testosterone pellets both prevent breast cancer in healthy women and reduce recurrence in breast cancer survivors, citing no evidence.

The reason this review is not generic is the source wording and the canonical claim label "trt did you know testosterone pellets can do more than just help." In this clip, the useful excerpt is: "The reason the testosterone pellets are the answer is that not only does it take the symptoms away of the menopause like all the stuff we just talked about, it's very protective, but it also helps prevent the recurrence of breast cancer..." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

No major oncology or endocrinology guideline, including those from ASCO or the Endocrine Society, endorses testosterone pellets for breast cancer prevention or recurrence reduction.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator claims subcutaneous testosterone pellets both prevent breast cancer in healthy women and reduce recurrence in breast cancer survivors, citing no evidence.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator claims subcutaneous testosterone pellets both prevent breast cancer in healthy women and reduce recurrence in breast cancer survivors, citing no evidence. Observational data from Glaser et al. (2013, 2019, Maturitas) shows association, not causation, and no major oncology guideline endorses testosterone for breast cancer prevention or recurrence reduction. Women considering testosterone therapy for menopause or survivorship symptoms should consult an oncologist or endocrinologist, not make decisions based on unqualified prevention claims.
  • The 2013 Glaser and Dimitrakakis study in Maturitas is the most-cited source for testosterone's potential breast-protective effects, but it was retrospective and single-center, not a randomized controlled trial.
  • No major oncology or endocrinology guideline, including those from ASCO or the Endocrine Society, endorses testosterone pellets for breast cancer prevention or recurrence reduction.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The 2013 Glaser and Dimitrakakis study in Maturitas is the most-cited source for testosterone's potential breast-protective effects, but it was retrospective and single-center, not a randomized controlled trial.
  • No major oncology or endocrinology guideline, including those from ASCO or the Endocrine Society, endorses testosterone pellets for breast cancer prevention or recurrence reduction.
  • Testosterone can aromatize to estradiol in women, which is a legitimate clinical concern in estrogen-receptor-positive breast cancer cases that the creator did not mention.
  • Testosterone therapy does have real, guideline-adjacent support for libido and some quality-of-life outcomes in menopausal women, but this evidence base does not extend to cancer prevention.
  • Breast cancer survivors considering any hormone therapy should consult their oncologist first, as risk-benefit calculations are highly individualized based on tumor receptor status and treatment history.
  • Using breast cancer prevention as a marketing angle for testosterone pellets is a significant regulatory gray area and reflects overclaiming relative to the actual strength of published evidence.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @performancemedicinetn actually say?

The creator made three distinct claims in this video. First, that testosterone pellets relieve menopause symptoms. Second, that testosterone is "very protective" and "helps prevent the recurrence of breast cancer" in patients who have already had it. Third, that testosterone pellets lower the risk of getting breast cancer in women who don't have it. These are not subtle suggestions. They are direct medical claims about cancer prevention and recurrence, delivered without a single caveat, study citation, or acknowledgment that this area of research is genuinely contested. The framing, "the testosterone pellets are the answer," treats a complicated and still-evolving scientific question as settled fact. It is not.

Does the science back this up?

Partially, and with significant caveats the creator left out entirely. The evidence on testosterone and breast cancer is real but preliminary, not conclusive. The most-cited work comes from Glaser and Dimitrakakis, who published a 2013 paper in Maturitas suggesting subcutaneous testosterone pellets, sometimes combined with anastrozole, were associated with lower breast cancer incidence in a retrospective cohort. A 2019 follow-up study by Glaser et al. in Maturitas reported reduced recurrence in hormone-receptor-positive breast cancer patients treated with testosterone pellets. These findings are interesting. They are not definitive. These are observational, single-center, retrospective studies, not randomized controlled trials. The biological mechanism, that testosterone may inhibit estrogen-driven breast cell proliferation via androgen receptor activation, is plausible and supported by in vitro and animal data. But "plausible mechanism plus small observational study" does not equal "this prevents breast cancer." The American Society of Clinical Oncology does not endorse testosterone as a breast cancer prevention strategy. Full stop.

What did they get wrong (or right)?

Let's give credit where it's due. The claim that testosterone has potential protective properties in breast tissue is not invented. There is a legitimate scientific hypothesis here, and researchers like Glaser and Dimitrakakis have built a case worth taking seriously. The assertion that testosterone addresses menopause symptoms is well-supported, including improvements in libido, mood, and energy, though evidence on hot flashes specifically is more mixed (Davis et al., 2008, Menopause).

What they got wrong is the certainty. Saying testosterone pellets "prevent" breast cancer and "prevent recurrence" as established fact misrepresents the current state of evidence. No major oncology or endocrinology body, including the Endocrine Society or ASCO, has endorsed testosterone pellets for breast cancer prevention or recurrence reduction. The creator also ignored the ongoing debate about testosterone aromatizing to estradiol in some women, which could theoretically have the opposite effect in estrogen-receptor-positive cancers. That's not a minor footnote. It's a reason oncologists approach this cautiously.

What should you actually know?

If you've had breast cancer and you're considering testosterone therapy, this is a conversation that needs to happen with your oncologist, not a TikTok video. Some researchers and clinicians do use testosterone in breast cancer survivors, particularly those with hormone-receptor-negative disease or those suffering significant quality-of-life issues from treatment-induced menopause. But it is an individualized, risk-stratified decision, not a blanket recommendation.

For women without breast cancer considering testosterone pellets for menopause or hormone optimization, the breast cancer prevention angle should not be the reason you pursue it. The evidence is too early-stage to use as a selling point. Testosterone therapy for women does have legitimate applications and a growing evidence base for quality of life outcomes. That case can stand on its own merits without overclaiming on cancer prevention. Clinics promoting testosterone pellets with breast cancer prevention language are making a regulatory and ethical stretch that patients deserve to know about.

  • Ask any prescriber citing breast cancer protection to show you the randomized controlled trial data. There isn't any yet.
  • If you are a breast cancer survivor, discuss hormone therapy only with your treating oncologist.
  • Testosterone therapy for menopause symptoms is a legitimate clinical option with real supporting evidence, but it is not a cancer vaccine.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Performance Med · TikTok creator

5.5K views on this video

Did you know testosterone pellets can do more than just help menopause symptoms? They may actually lower your risk of breast cancer and help prevent recurrence, too. Women’s health matters—get informe

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the 2013 glaser?

The 2013 Glaser and Dimitrakakis study in Maturitas is the most-cited source for testosterone's potential breast-protective effects, but it was retrospective and single-center, not a randomized controlled trial.

What does the video say about no major oncology?

No major oncology or endocrinology guideline, including those from ASCO or the Endocrine Society, endorses testosterone pellets for breast cancer prevention or recurrence reduction.

What does the video say about testosterone can aromatize to estradiol in women,?

Testosterone can aromatize to estradiol in women, which is a legitimate clinical concern in estrogen-receptor-positive breast cancer cases that the creator did not mention.

What does the video say about testosterone therapy does have real, guideline-adjacent support for libido?

Testosterone therapy does have real, guideline-adjacent support for libido and some quality-of-life outcomes in menopausal women, but this evidence base does not extend to cancer prevention.

What does the video say about breast cancer survivors considering any hormone therapy should consult their?

Breast cancer survivors considering any hormone therapy should consult their oncologist first, as risk-benefit calculations are highly individualized based on tumor receptor status and treatment history.

What does the video say about using breast cancer prevention as a marketing angle for testosterone?

Using breast cancer prevention as a marketing angle for testosterone pellets is a significant regulatory gray area and reflects overclaiming relative to the actual strength of published evidence.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Performance Med, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.